21 results
10-Q
2020 Q3
NRIX
Nurix Therapeutics Inc
14 Oct 20
Quarterly report
4:02pm
limitations may hinder our ability to recoup our investment in one or more product candidates, even if our product candidates obtain marketing approval
10-K
laen94x3d7 s6b1
16 Feb 21
Annual report
4:11pm
DRS/A
cauh4rri6ej28hy6sqqo
10 Jun 20
Draft registration statement (amended)
12:00am
424B4
mimqmxche96
24 Jul 20
Prospectus supplement with pricing info
4:06pm
S-1/A
qte0s6d4qb2r1
20 Jul 20
IPO registration (amended)
6:32am
DRS
z9lveru siec3g3o
5 May 20
Draft registration statement
12:00am